Product Information
GNP LIDOCAINE HCL 4% CREAM is a generic product labeled by AmerisourceBergen, priced at $0.0521 per GM under NDC 46122061410. Its NADAC has been published 246 times since Jan 19, 2022.
Strength
4 g/100g
Manufacturer
AmerisourceBergenNDC
46122061410
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M017On Market Since
2/24/2020
Pharmacological Classes
Price Statistics
The NADAC for GNP LIDOCAINE HCL 4% CREAM has been published 246 times since Jan 19, 2022, and over the history we have for it it has risen 26.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0521 per GM |
|---|---|
| All-time high | $0.0529 (Mar 11, 2026) |
| All-time low | $0.0391 (Mar 23, 2022) |
| 52-week high | $0.0529 |
| 52-week low | $0.0510 |
| Median price | $0.0484 |
| Average price | $0.0479 |
| Largest weekly change | +13.7% (Oct 19, 2022) |
| Weeks tracked | 246 |
| Tracking since | Jan 19, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lidocaine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP LIDOCAINE HCL 4% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for GNP LIDOCAINE HCL 4% CREAM, manufactured by AmerisourceBergen, is $0.0521 per GM (NDC 46122061410), effective Sep 30, 2026.
How has the price of GNP LIDOCAINE HCL 4% CREAM changed over time?
Over the history we have for it, the NADAC for GNP LIDOCAINE HCL 4% CREAM has risen 26.9%. It has been tracked across 246 weekly CMS publications since Jan 19, 2022.
What are the highest and lowest recorded NADAC prices for GNP LIDOCAINE HCL 4% CREAM?
Since Jan 19, 2022, the NADAC for GNP LIDOCAINE HCL 4% CREAM has ranged from a low of $0.0391 (Mar 23, 2022) to a high of $0.0529 (Mar 11, 2026), with a median of $0.0484 per GM.
Are there cheaper alternatives to GNP LIDOCAINE HCL 4% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of GNP LIDOCAINE HCL 4% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GNP LIDOCAINE HCL 4% CREAM?
GNP LIDOCAINE HCL 4% CREAM (NDC 46122061410) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.